VECTRON BIOSOLUTIONS AS

Operating

Forske og utvikle teknologier for produksjon av rekombinante proteiner og kommersialisering herav, samt utføre tjenester og annen virksomhet som står i naturlig forhold til dette. Selskapet kan også eie aksjer i andre selskaper.

Industri: Forskning, utvikling og salg av teknologi for produksjon av rekombinante proteiner.

Organization

CEO: TE
Trond Erik Vee Aune1976
Chairman of the board: CC
Carl-Åke Carlsson1963
Years since formation: 18 years; since Jul 1, 2008
Type: Limited company
VAT registered: Yes
Number of employees: 0

Ownership

Number of shares and share classes: 3,625,284; 2 share classes
Total number of shareholders: 31; 16 companies, 15 persons

Financials

Total operating income 2024: 2,040,717; NOK
Annual total result 2024: -12,739,604; NOK
Total equity 2024: 9,554,765; NOK

Last update: Dec 12, 2025

Management

Management / administration

Name	Role	Shares
TE Trond Erik Vee Aune 1976	Managing Director/CEO	-

Board

Name	Role	Shares
CC Carl-Åke Carlsson 1963	Chairman	-
TE Trond Erik Vee Aune 1976	Board Member	-
TE Tom Edward Pike 1960	Board Member	-
JE Jan Erik Foss 1970	Board Member	-
RV Reinhard Vogt 1955	Board Member	-

Others

Name	Role	Shares
B BDO AS	Auditor	-
S SPAREBANK 1 REGNSKAPSHUSET SMN AS	Accountant	-

Top 10 individual shareholders

Name	Role	Shares
TH Trygve Håbrekke Jan 1963	-	4.97 % indirectly
EV Erik Vee Aune Trond 1976	-	2.4 % directly
SA Samsonsen Alexander 1975	-	1.44 % indirectly
VM Valla Marit 1976	-	1.41 % directly

Last update: Apr 13, 2023

Ownership

Company shareholders

Name	Share class	Total number of shares	Share
DC Dynamk Capital Llc	A-shares	808,149	22.29 %
L LEIV EIRIKSSON NYSKAPING AS	Ordinary shares	703,723	19.41 %
E EIDCO AS	Ordinary shares	522,133	14.4 %
TT T3s Technologies Inc	Ordinary shares	404,991	11.17 %
S SPAREBANK 1 SMN INVEST AS	Ordinary shares	220,000	6.07 %
I INVESTITUDE AS	Ordinary shares	180,000	4.97 %
S SVANHILD OG ARNE MUSTS FOND FOR MEDISINSK FORSKNING STI	Ordinary shares	100,397	2.77 %
H HELIFT AS	Ordinary shares	100,000	2.76 %
EV Erik Vee Aune Trond 1976	Ordinary shares	85,320	2.35 %
B BAF HOLDING AS	Ordinary shares	65,000	1.79 %
K KONAYUKI AS	Ordinary shares	58,000	1.6 %
E EIDCO AS	A-shares	55,000	1.52 %
VM Valla Marit 1976	Ordinary shares	51,035	1.41 %
CC Core Competence Ab	Ordinary shares	49,014	1.35 %
M MUST INVEST AS	Ordinary shares	41,667	1.15 %
L LEIV EIRIKSSON NYSKAPING AS	A-shares	39,412	1.09 %
VT Valla Tone 1974	Ordinary shares	30,035	0.83 %
T TURTLE INVEST AS	Ordinary shares	28,300	0.78 %
C CÅC INVEST AS	Ordinary shares	25,067	0.69 %
T TURTLE INVEST AS	A-shares	9,000	0.25 %
K KONAYUKI AS	A-shares	8,500	0.23 %
EP Edward Pike Tom 1960	Ordinary shares	6,667	0.18 %
VB Valla Birgit 1977	Ordinary shares	5,500	0.15 %
VK Valla Kristin 1975	Ordinary shares	5,500	0.15 %
MB Martha Blatny Janet 1966	Ordinary shares	4,433	0.12 %
B BAF HOLDING AS	A-shares	3,500	0.1 %
KP Karunankarab Ponniah	Ordinary shares	3,483	0.1 %
BI Bakke Ingrid 1963	Ordinary shares	3,333	0.09 %
LR Lale Rahmi 1977	Ordinary shares	3,333	0.09 %
BL Berg Laila 1973	Ordinary shares	3,000	0.08 %
EV Erik Vee Aune Trond 1976	A-shares	1,792	0.05 %

Last update: Sep 25, 2026

Financials

in NOK

Summary

Year	2024	2023	2022	2021
Total operating income	2,040,717	5,423,673	7,568,873	7,309,200
Annual Total Result	-12,739,604	-12,551,288	-7,976,851	-5,482,193
Total assets	21,584,884	27,038,284	39,927,953	45,063,220
Total liabilities	12,030,119	4,739,925	5,082,297	5,521,969
Total equity	9,554,765	22,298,359	34,845,656	39,541,252

P&L

Year	2024	2023	2022	2021
Total operating income	2,040,717	5,423,673	7,568,873	7,309,200
Total operating costs	14,326,356	17,132,337	15,636,187	13,149,468
Operating result	-12,285,639	-11,708,664	-8,067,314	-5,840,267
Financial income/costs	-453,965	-2,066	90,463	358,075
Profit before tax	-12,739,604	-11,710,730	-7,976,851	-5,482,193
Total tax & extraordinary income/cost	0	840,558	0	0
Annual Total Result	-12,739,604	-12,551,288	-7,976,851	-5,482,193

Balance overview

Year	2024	2023	2022	2021
Total fixed assets	18,397,148	18,903,568	21,930,400	23,166,005
Total current assets	3,187,736	8,134,716	17,997,553	21,897,216
Total assets	21,584,884	27,038,284	39,927,953	45,063,220
Short term debt	3,720,248	2,806,613	2,748,977	2,788,641
Long term debt	8,309,871	1,933,312	2,333,320	2,733,328
Total liabilities	12,030,119	4,739,925	5,082,297	5,521,969
Contributed capital	9,554,765	22,298,359	34,845,656	39,541,252
Retained earnings	0	0	0	0
Total equity	9,554,765	22,298,359	34,845,656	39,541,252
Total equity and liabilities	21,584,884	27,038,284	39,927,953	45,063,220

Classification

21st company classification

BETA

Small company

Type of organization

Limited company

Classification of institutional sector

INNL

Domestic sectors

A_IKKE-FIN

Non-financial corporations

2100

Private non-financial incorporated enterprises

Standard industrial classification

VECTRON BIOSOLUTIONS AS992 779 837